About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cdx2tm2Fbe
targeted mutation 2, F Beck
MGI:5308966
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Cdx1tm1Pgr/Cdx1tm1Pgr
Cdx2tm2Fbe/Cdx2tm2Fbe
Tg(Cyp1a1-cre/ERT)1Dwi/0
involves: 129 * C57BL/6 * CBA MGI:5308974
cn2
Cdx2tm1Fbe/Cdx2tm2Fbe
Edil3Tg(Sox2-cre)1Amc/Edil3+
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA MGI:5308975
cn3
Cdx2tm2Fbe/Cdx2tm2Fbe
Lgr5tm1(cre/ERT2)Cle/Lgr5+
involves: 129P2/OlaHsd * C57BL/6 MGI:5308972
cn4
Cdx2tm2Fbe/Cdx2tm2Fbe
Tg(Cyp1a1-cre/ERT)1Dwi/0
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:5308973


Genotype
MGI:5308974
cn1
Allelic
Composition
Cdx1tm1Pgr/Cdx1tm1Pgr
Cdx2tm2Fbe/Cdx2tm2Fbe
Tg(Cyp1a1-cre/ERT)1Dwi/0
Genetic
Background
involves: 129 * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdx1tm1Pgr mutation (1 available); any Cdx1 mutation (13 available)
Cdx2tm2Fbe mutation (0 available); any Cdx2 mutation (22 available)
Tg(Cyp1a1-cre/ERT)1Dwi mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• cystic vesicles appear 1 week after treatment with tamoxifen and BNF, earlier than in mutant mice wild-type for Cdx1

endocrine/exocrine glands
• cystic vesicles appear 1 week after treatment with tamoxifen and BNF, earlier than in mutant mice wild-type for Cdx1




Genotype
MGI:5308975
cn2
Allelic
Composition
Cdx2tm1Fbe/Cdx2tm2Fbe
Edil3Tg(Sox2-cre)1Amc/Edil3+
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdx2tm1Fbe mutation (0 available); any Cdx2 mutation (22 available)
Cdx2tm2Fbe mutation (0 available); any Cdx2 mutation (22 available)
Edil3Tg(Sox2-cre)1Amc mutation (5 available); any Edil3 mutation (42 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
embryo




Genotype
MGI:5308972
cn3
Allelic
Composition
Cdx2tm2Fbe/Cdx2tm2Fbe
Lgr5tm1(cre/ERT2)Cle/Lgr5+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdx2tm2Fbe mutation (0 available); any Cdx2 mutation (22 available)
Lgr5tm1(cre/ERT2)Cle mutation (1 available); any Lgr5 mutation (57 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• by 6 weeks after treatment cystic vesicles persist and are often filled with mucous and detritus
• an excess of Paneth cells are found by 19-62 weeks after treatment and these cells contain an abnormally abundant number of normal looking secretory granules
• 4 weeks after treatment with tamoxifen a low level of excess mucous secretion is seen
• by 6 weeks after treatment dying Paneth cells are commonly seen

cellular
• recombined cells fail to migrate out of the crypts and up the villi in the intestine

endocrine/exocrine glands
• by 6 weeks after treatment cystic vesicles persist and are often filled with mucous and detritus
• an excess of Paneth cells are found by 19-62 weeks after treatment and these cells contain an abnormally abundant number of normal looking secretory granules




Genotype
MGI:5308973
cn4
Allelic
Composition
Cdx2tm2Fbe/Cdx2tm2Fbe
Tg(Cyp1a1-cre/ERT)1Dwi/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdx2tm2Fbe mutation (0 available); any Cdx2 mutation (22 available)
Tg(Cyp1a1-cre/ERT)1Dwi mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• 4 weeks after treatment with tamoxifen and BNF a bias towards the production of secretory cells is detected with an excess of mucous-secreting cells in the upper part of the crypts and towards the bases of the villi
• 4 weeks after treatment with tamoxifen and BNF crypts become sealed off into cystic vesicles and display a severe degree of hypoproliferation
• by 6 weeks after treatment cystic vesicles persist and are often filled with mucous and detritus
• cystic vesicles continue to persist 19-62 weeks after treatment although the surface epithelium consists of unrecombined cells
• abnormal and frequently moribund 4 weeks after treatment with tamoxifen and BNF
• an excess of Paneth cells are found by 19-62 weeks after treatment and these cells contain an abnormally abundant number of normal looking secretory granules
• in some mice polyps containing large irregular vesicles develop after treatment with tamoxifen and BNF
• by 6 weeks after treatment in isolated areas of the distal ileum recombined crypts have replaced the villi
• beyond 19 weeks these recombined regions develop into antral-like branched tubular glands secreting PASpositive, Alcian Blue-negative mucous
• 4 weeks after treatment with tamoxifen and BNF villi are misshapen
• 4 weeks after treatment with tamoxifen and beta-naphthoflavone (BNF) the gut becomes abnormally viscid
• by 6 weeks after treatment dying Paneth cells are commonly seen
• by 6 weeks after treatment dying Paneth cells are commonly seen

cellular
• recombined cells fail to migrate out of the crypts and up the villi in the intestine

endocrine/exocrine glands
• 4 weeks after treatment with tamoxifen and BNF crypts become sealed off into cystic vesicles and display a severe degree of hypoproliferation
• by 6 weeks after treatment cystic vesicles persist and are often filled with mucous and detritus
• cystic vesicles continue to persist 19-62 weeks after treatment although the surface epithelium consists of unrecombined cells
• abnormal and frequently moribund 4 weeks after treatment with tamoxifen and BNF
• an excess of Paneth cells are found by 19-62 weeks after treatment and these cells contain an abnormally abundant number of normal looking secretory granules





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory